Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06276764 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv5
  2. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 15, 2024 to Oct 15, 2024
    • Interventions: LINFU® (Diagnostic Test), Standard imaging tests (Diagnostic Test) to LINFU® (Diagnostic Test)
    v4
  3. Primary completion date: Mar 30, 2034 to Sep 30, 2034
    • Start date: Jun 15, 2024 to Sep 15, 2024
    • Study completion date: May 1, 2034 to Dec 1, 2034
    v3
  4. Start date: Apr 15, 2024 to Jun 15, 2024v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this study, LINFU® will be evaluated in patients who have been identified with IPMN to determine if it can be used to help identify early, pancreatic ductal adenocarcinoma and its noninvasive precursor lesions (dysplasia). The study will also help determine if LINFU® results in earlier intervention, treatment and improvement in patient outcomes.
Trial Details
NCT Number NCT06276764
Lead Sponsor Adenocyte, LLC
Conditions
(from sponsor)		 IPMN, Pancreatic, Pancreas Cancer, Pancreatic Cyst
Related terms Pancreatic Cyst, Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov